Cardiac iron deposition in idiopathic hemochromatosis: histologic and analytic assessment of 14 hearts from autopsy
LJ Olson,
WD Edwards,
JT McCall,
DM Ilstrup,
and
BJ Gersh
Department of Pathology, Mayo Clinic, Rochester, Minnesota 55905.
In each heart taken from autopsies of 14 men with idiopathic hemochromatosis, the conduction system, atria and 10 sites in the ventricles were histologically graded for stainable iron. Stainable iron was exclusively sarcoplasmic; none was observed in the interstitium. The histologic grade for the same anatomic site varied among hearts and among different anatomic sites in the same heart. Ten hearts had stainable iron in all ventricular sites; one of the three hearts from patients who had undergone therapeutic phlebotomy had no iron at any site. Seven hearts had iron in the atria but at a lesser grade than that found in the ventricles; six hearts had mild focal iron deposition in the atrioventricular conduction system. None of the 14 hearts had stainable iron in the sinus node. Elemental iron was quantitated by atomic absorption spectroscopy in ventricular specimens contiguous to those studied histologically and also in age-matched control hearts. Elemental iron content was markedly increased in hearts with idiopathic hemochromatosis compared with control hearts (p less than 0.01). The quantity of elemental iron varied greatly, similar to stainable iron, but was highest subepicardially. Among the hearts from the 11 patients without prior phlebotomy, three had no stainable iron in the right ventricular septal subendocardium, suggesting that sampling error may be a problem in the evaluation of hemochromatosis by endomyocardial biopsy. The sarcoplasmic location of the iron indicates that cardiac involvement in idiopathic hemochromatosis represents a storage disease and not an infiltrative process; this finding is consistent with the normal ventricular wall thicknesses observed.
This article has been cited by other articles:

|
 |

|
 |
 
A Pepe, V Positano, M Capra, A Maggio, C L Pinto, A Spasiano, G Forni, G Derchi, B Favilli, G Rossi, et al.
Myocardial scarring by delayed enhancement cardiovascular magnetic resonance in thalassaemia major
Heart,
October 15, 2009;
95(20):
1688 - 1693.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-P. Carpenter, S. K Prasad, and D. J Pennell
Myocardial fibrosis in thalassaemia: recalling the past or telling the future?
Heart,
October 15, 2009;
95(20):
1646 - 1647.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-T. Zhu, W.-Y. Feng, Y. Wang, B. Wang, M. Wang, H. Ouyang, Y.-L. Zhao, and Z.-F. Chai
Particokinetics and Extrapulmonary Translocation of Intratracheally Instilled Ferric Oxide Nanoparticles in Rats and the Potential Health Risk Assessment
Toxicol. Sci.,
February 1, 2009;
107(2):
342 - 351.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Walker Jr., R. G. Morrison, L. Dornon, J. P. Laurino, S. M. Walker, M. Studeny, P. S. Wehner, K. M. Rice, M. Wu, and E. R. Blough
Acetaminophen Combinations Protect Against Iron-Induced Cardiac Damage in Gerbils
Ann. Clin. Lab. Sci.,
January 1, 2009;
39(4):
378 - 385.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. M. Hess, W. McKenna, and H.-P. Schultheiss
CHAPTER 18 Myocardial Disease
ESC Textbook of Cardiovascular Medicine,
January 1, 2009;
2(1):
med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Nagayoshi, M. Nakayama, S. Suzuki, J. Hokamaki, H. Shimomura, K. Tsujita, M. Fukuda, T. Yamashita, Y. Nakamura, S. Sugiyama, et al.
A Q312X mutation in the hemojuvelin gene is associated with cardiomyopathy due to juvenile haemochromatosis
Eur J Heart Fail,
October 1, 2008;
10(10):
1001 - 1006.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. T. Cooper, K. L. Baughman, A. M. Feldman, A. Frustaci, M. Jessup, U. Kuhl, G. N. Levine, J. Narula, R. C. Starling, J. Towbin, et al.
The role of endomyocardial biopsy in the management of cardiovascular disease: A Scientific Statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology
Eur. Heart J.,
December 2, 2007;
28(24):
3076 - 3093.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. T. Cooper, K. L. Baughman, A. M. Feldman, A. Frustaci, M. Jessup, U. Kuhl, G. N. Levine, J. Narula, R. C. Starling, J. Towbin, et al.
The Role of Endomyocardial Biopsy in the Management of Cardiovascular Disease: A Scientific Statement From the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology
J. Am. Coll. Cardiol.,
November 6, 2007;
50(19):
1914 - 1931.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. T. Cooper, K. L. Baughman, A. M. Feldman, A. Frustaci, M. Jessup, U. Kuhl, G. N. Levine, J. Narula, R. C. Starling, J. Towbin, et al.
The Role of Endomyocardial Biopsy in the Management of Cardiovascular Disease: A Scientific Statement From the American Heart Association, the American College of Cardiology, and the European Society of Cardiology
Circulation,
November 6, 2007;
116(19):
2216 - 2233.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Wood, M. Otto-Duessel, M. Aguilar, H. Nick, M. D. Nelson, T. D. Coates, H. Pollack, and R. Moats
Cardiac Iron Determines Cardiac T2*, T2, and T1 in the Gerbil Model of Iron Cardiomyopathy
Circulation,
July 26, 2005;
112(4):
535 - 543.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Palka, A. Lange, J. Atherton, W. J. Stafford, and D. J. Burstow
Biventricular diastolic behaviour in patients with hypertrophic and hereditary hemochromatosis cardiomyopathies
Eur J Echocardiogr,
October 1, 2004;
5(5):
356 - 366.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Goland, N. Beilinson, A. Kaftouri, S. Shimoni, A. Caspi, and S. D.H. Malnick
Hemochromatosis mutations are not linked to dilated cardiomyopathy in Israeli patients
Eur J Heart Fail,
August 1, 2004;
6(5):
547 - 550.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Ocel, W. D. Edwards, H. D. Tazelaar, L. M. Petrovic, B. S. Edwards, and P. S. Kamath
Heart and Liver Disease in 32 Patients Undergoing Biopsy of Both Organs, With Implications for Heart or Liver Transplantation
Mayo Clin. Proc.,
April 1, 2004;
79(4):
492 - 501.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
P. D. Jensen, F. T. Jensen, T. Christensen, H. Eiskjaer, U. Baandrup, and J. L. Nielsen
Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool
Blood,
June 1, 2003;
101(11):
4632 - 4639.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Ishizaka, K. Saito, H. Mitani, I. Yamazaki, M. Sata, S.-i. Usui, I. Mori, M. Ohno, and R. Nagai
Iron Overload Augments Angiotensin II-Induced Cardiac Fibrosis and Promotes Neointima Formation
Circulation,
October 1, 2002;
106(14):
1840 - 1846.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Walker
The heart in thalassaemia
Eur. Heart J.,
January 2, 2002;
23(2):
102 - 105.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. J. Bartfay, F. Dawood, W. H. Wen, D. C. Lehotay, D. Hou, E. Bartfay, X. Luo, P. H. Backx, and P. P. Liu
Cardiac function and cytotoxic aldehyde production in a murine model of chronic iron-overload
Cardiovasc Res,
September 1, 1999;
43(4):
892 - 900.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. D Horwitz and E. A Rosenthal
Iron-mediated cardiovascular injury
Vascular Medicine,
May 1, 1999;
4(2):
93 - 99.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
N. F. Olivieri and G. M. Brittenham
Iron-Chelating Therapy and the Treatment of Thalassemia
Blood,
February 1, 1997;
89(3):
739 - 761.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Whittaker, F. A. Hines, M. G. Robl, and V. C. Dunkel
Histopathological Evaluation of Liver, Pancreas, Spleen, and Heart from Iron-Overloaded Sprague-Dawley Rats*1,2
Toxicol Pathol,
September 1, 1996;
24(5):
558 - 563.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Gore and J. T. Fallon
Case 31-1994- A 25-Year-Old Man with the Recent Onset of Diabetes Mellitus and Congestive Heart Failure
N. Engl. J. Med.,
August 18, 1994;
331(7):
460 - 466.
[Full Text]
|
 |
|

|
 |

|
 |
 
K. A. Schwartz, J. Fisher, and E. T. Adams
Morphologic Investigations of the Guinea Pig Model of Iron Overload
Toxicol Pathol,
April 1, 1993;
21(3):
311 - 320.
[Abstract]
[PDF]
|
 |
|
|